News + Filings Transactions
|
Gerngross Tillman U.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/16/2022 | Alector, Inc. | ALEC | Grant | Stock Option (right to buy) | 18.9k | $8.07 | $152.7k | | 06/16/2022 |
| 06/16/2022 | Alector, Inc. | ALEC | Grant | Common Stock | 9.5k | $0.00 | $0 | | 06/16/2022 |
| 01/30/2022 | Invivyd, Inc. | | Grant | Stock Option (Right to Buy) | 175k | $6.78 | $1.2M | | 01/30/2022 |
| 08/10/2021 | Invivyd, Inc. | | Conversion | Common Stock | 25.9M | $0.00 | $0 | See Footnote | 08/10/2021 |
| 08/10/2021 | Invivyd, Inc. | | Conversion | Series A Preferred Stock | 5M | $0.00 | $0 | See Footnote | 08/10/2021 |
| 08/10/2021 | Invivyd, Inc. | | Conversion | Series B Preferred Stock | 44.1k | $0.00 | $0 | See Footnote | 08/10/2021 |
| 08/10/2021 | Invivyd, Inc. | | Conversion | Series C Preferred Stock | 128.1k | $0.00 | $0 | See Footnote | 08/10/2021 |
| 06/17/2021 | Alector, Inc. | ALEC | Grant | Stock Option (right to buy) | 25.7k | $21.37 | $549.4k | | 06/17/2021 |
| 05/11/2020 | Alector, Inc. | ALEC | Grant | Stock Option (right to buy) | 19.3k | $29.09 | $560.7k | | 05/11/2020 |
| 05/10/2019 | Alector, Inc. | ALEC | Grant | Stock Option (right to buy) | 20k | $20.05 | $401k | | 05/10/2019 |
| 02/11/2019 | Alector, Inc. | ALEC | Conversion | Series E Preferred Stock | 52.8k | $0.00 | $0 | | 02/11/2019 |
| 02/11/2019 | Alector, Inc. | ALEC | Conversion | Series C Preferred Stock | 374.5k | $0.00 | $0 | | 02/11/2019 |
| 02/11/2019 | Alector, Inc. | ALEC | Conversion | Common Stock | 52.8k | $0.00 | $0 | | 02/11/2019 |
| 02/11/2019 | Alector, Inc. | ALEC | Conversion | Common Stock | 374.5k | $0.00 | $0 | | 02/11/2019 |
| 06/05/2018 | X4 Pharmaceuticals, Inc | XFOR | Grant | Stock Option (right to buy) | 10k | $16.99 | $169.9k | | 06/05/2018 |
| 11/20/2017 | X4 Pharmaceuticals, Inc | XFOR | Conversion | Common Stock | 90.3k | $0.00 | $0 | | 11/20/2017 |
| 11/20/2017 | X4 Pharmaceuticals, Inc | XFOR | Purchase | Common Stock | 200k | $10.00 | $2M | | 11/20/2017 |
| 11/20/2017 | X4 Pharmaceuticals, Inc | XFOR | Conversion | Series D Convertible Preferred Stock | 308.1k | $0.00 | $0 | | 11/20/2017 |
| 11/15/2017 | X4 Pharmaceuticals, Inc | XFOR | Grant | Stock Option (right to buy) | 25k | $10.00 | $250k | | 11/15/2017 |
| 11/15/2017 | X4 Pharmaceuticals, Inc | XFOR | Grant | | 7.3k | $10.00 | $73.2k | | 11/15/2017 |
|